Dynavax Technologies Corp (DVAX)
12.36
+0.19
(+1.56%)
USD |
NASDAQ |
Nov 21, 16:00
12.38
+0.02
(+0.12%)
Pre-Market: 20:00
Dynavax Technologies Net Income (Quarterly): 17.59M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 17.59M |
| June 30, 2024 | 11.39M |
| March 31, 2024 | -8.721M |
| December 31, 2023 | 0.219M |
| September 30, 2023 | 14.29M |
| June 30, 2023 | 3.431M |
| March 31, 2023 | -24.33M |
| December 31, 2022 | 67.73M |
| September 30, 2022 | 63.81M |
| June 30, 2022 | 128.76M |
| March 31, 2022 | 32.86M |
| December 31, 2021 | 99.78M |
| September 30, 2021 | -28.43M |
| June 30, 2021 | 4.473M |
| March 31, 2021 | 0.891M |
| December 31, 2020 | -15.47M |
| September 30, 2020 | 4.401M |
| June 30, 2020 | -51.58M |
| March 31, 2020 | -12.60M |
| December 31, 2019 | -36.76M |
| September 30, 2019 | -33.46M |
| June 30, 2019 | -42.71M |
| March 31, 2019 | -39.67M |
| December 31, 2018 | -39.97M |
| September 30, 2018 | -40.53M |
| Date | Value |
|---|---|
| June 30, 2018 | -39.44M |
| March 31, 2018 | -38.96M |
| December 31, 2017 | -27.42M |
| September 30, 2017 | -22.13M |
| June 30, 2017 | -20.32M |
| March 31, 2017 | -25.29M |
| December 31, 2016 | -21.74M |
| September 30, 2016 | -34.69M |
| June 30, 2016 | -28.99M |
| March 31, 2016 | -27.02M |
| December 31, 2015 | -26.86M |
| September 30, 2015 | -30.12M |
| June 30, 2015 | -23.59M |
| March 31, 2015 | -26.22M |
| December 31, 2014 | -22.29M |
| September 30, 2014 | -29.82M |
| June 30, 2014 | -24.78M |
| March 31, 2014 | -13.84M |
| December 31, 2013 | -13.06M |
| September 30, 2013 | -15.68M |
| June 30, 2013 | -17.16M |
| March 31, 2013 | -20.82M |
| December 31, 2012 | -20.54M |
| September 30, 2012 | -17.79M |
| June 30, 2012 | -15.11M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-51.58M
Minimum
Jun 2020
128.76M
Maximum
Jun 2022
13.59M
Average
3.916M
Median
Net Income (Quarterly) Benchmarks
| Biogen Inc | 388.50M |
| Repligen Corp | -0.654M |
| West Pharmaceutical Services Inc | 136.00M |
| Janux Therapeutics Inc | -28.06M |
| XOMA Royalty Corp | -17.24M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 80.63M |
| Total Expenses (Quarterly) | 70.55M |
| EPS Diluted (Quarterly) | 0.12 |
| Enterprise Value | 1.084B |
| Gross Profit Margin (Quarterly) | 83.77% |
| Profit Margin (Quarterly) | 21.82% |
| Earnings Yield | 1.05% |
| Normalized Earnings Yield | 1.052 |